US biotechnology company Acorda Therapeutics is focused on developing therapies for multiple sclerosis, spinal cord injury and other neurological conditions.
Actavis (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.
Actelion is a Swiss biotech firm. It has subsidiaries with marketing and sales in more than 30 countries, covering all key pharmaceutical markets worldwide. It is the largest biotechnology company in Europe.